Target Price | $4.96 |
Price | $0.33 |
Potential |
1,380.09%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target ImmunoPrecise Antibodies Ltd 2026 .
The average ImmunoPrecise Antibodies Ltd target price is $4.96.
This is
1,380.09%
register free of charge
$6.93
1,969.10%
register free of charge
$2.98
791.08%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend ImmunoPrecise Antibodies Ltd to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the ImmunoPrecise Antibodies Ltd stock has an average upside potential 2026 of
1,380.09%
register free of charge
|
Apr '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 18.16 | 17.45 |
16.86% | 3.88% |
2 Analysts have issued a sales forecast ImmunoPrecise Antibodies Ltd 2025 . The average ImmunoPrecise Antibodies Ltd sales estimate is
This results in the following potential growth metrics:
Apr '24 |
2025 Estimates |
|
---|---|---|
EV/Sales | 1.01 |
Based on analysts' sales estimates for 2025, the ImmunoPrecise Antibodies Ltd stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
ImmunoPrecise Antibodies Ltd...
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. | Locked ➜ Locked | Locked | Dec 11 2024 |
HC Wainwright & Co. | Locked ➜ Locked | Locked | Sep 17 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Dec 11 2024 |
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Sep 17 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.